Related Experiment Video
Updated: Jul 19, 2025

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Changes in C-Peptide Values in Children with Type 1 Diabetes - a Three-Year Study
Carmen Nicoleta Novac1, Doina-Andrada Mihai2,3, Anca Andreea Boboc1,2
1"M. S. Curie" Emergency Clinical Hospital for Children, Bucharest, Romania.
Younger children with type 1 diabetes mellitus (T1DM) experience faster C-peptide decline. Higher initial C-peptide levels and absence of diabetic ketoacidosis (DKA) at diagnosis predict better residual insulin secretion over three years.
Area of Science:
- Endocrinology
- Pediatric Diabetes Research
- Metabolic Disease Monitoring
Background:
- C-peptide (CP) is a key biomarker for assessing endogenous insulin production in type 1 diabetes mellitus (T1DM) patients on insulin therapy.
- Monitoring CP levels is crucial for understanding disease progression and residual beta-cell function.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cell Specific Gene Expression
Diabetes: Symptoms, Diagnosis, and Complications
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

